4. Shockwave Medical
Venture capital raised: $96.9 million
Shockwave Medical secured $96.9 million in an initial public offering during Q1 last year, according to the MoneyTree report.
Shockwave Medical is developing intravascular lithotripsy technology to treat calcified peripheral vascular, coronary vascular and heart valve diseases.
The company announced its initial public offering worth $70 million in February 2019 and later set terms that said it was looking to bring in about $75 million. Shockwave in March said it raised nearly $97 million from the IPO and signed a private-placement deal with Abiomed for another $10 million. It filed another $75 million offering in November 2019.
Shockwave Medical won breakthrough device designation from the FDA in September for its sonic pressure-wave system.